Insider Selling: Pediatrix Medical Group, Inc. (NYSE:MD) CFO Sells 17,438 Shares of Stock

Pediatrix Medical Group, Inc. (NYSE:MD) CFO C Marc Richards sold 17,438 shares of the firm’s stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $10.08, for a total value of $175,775.04. Following the sale, the chief financial officer now directly owns 175,347 shares of the company’s stock, valued at $1,767,497.76. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

C Marc Richards also recently made the following trade(s):

• On Friday, August 9th, C Marc Richards sold 32,562 shares of Pediatrix Medical Group stock. The shares were sold at an average price of $10.08, for a total value of $328,224.96.

Pediatrix Medical Group Stock Down 0.2 %

Shares of NYSE MD traded down $0.02 during midday trading on Tuesday, hitting $10.11. 617,009 shares of the company’s stock were exchanged, compared to its average volume of 962,491. The firm’s fifty day simple moving average is $7.70 and its 200-day simple moving average is $8.48. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.61 and a quick ratio of 1.72. The company has a market cap of $850.76 million, a PE ratio of -11.89, a P/E/G ratio of 1.78 and a beta of 1.56. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $15.00.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.03. The business had revenue of $504.30 million during the quarter, compared to the consensus estimate of $505.49 million. Pediatrix Medical Group had a negative net margin of 12.58% and a positive return on equity of 10.59%. The company’s revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.37 EPS. Research analysts predict that Pediatrix Medical Group, Inc. will post 1.13 EPS for the current fiscal year.

Hedge Funds Weigh In On Pediatrix Medical Group

Several large investors have recently bought and sold shares of the stock. Allspring Global Investments Holdings LLC increased its position in shares of Pediatrix Medical Group by 226.9% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 36,161 shares of the company’s stock worth $336,000 after purchasing an additional 25,098 shares in the last quarter. Louisiana State Employees Retirement System purchased a new stake in Pediatrix Medical Group in the fourth quarter valued at approximately $385,000. Federated Hermes Inc. boosted its holdings in shares of Pediatrix Medical Group by 5.0% in the fourth quarter. Federated Hermes Inc. now owns 283,793 shares of the company’s stock valued at $2,639,000 after acquiring an additional 13,497 shares during the period. Wedge Capital Management L L P NC grew its position in shares of Pediatrix Medical Group by 66.8% during the fourth quarter. Wedge Capital Management L L P NC now owns 81,988 shares of the company’s stock worth $762,000 after acquiring an additional 32,831 shares during the last quarter. Finally, SummerHaven Investment Management LLC increased its holdings in shares of Pediatrix Medical Group by 2.3% in the 4th quarter. SummerHaven Investment Management LLC now owns 52,900 shares of the company’s stock valued at $492,000 after acquiring an additional 1,208 shares during the period. Institutional investors and hedge funds own 97.71% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on MD shares. StockNews.com raised shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research note on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft upgraded Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 price objective on the stock in a research note on Friday, June 7th. UBS Group upped their price target on Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a report on Friday. Finally, Truist Financial decreased their price objective on Pediatrix Medical Group from $10.00 to $8.00 and set a “hold” rating for the company in a research note on Monday, July 15th. Six analysts have rated the stock with a hold rating, According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $8.90.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.